fda ruling on glp 1 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA Targets GLP-1 and Peptide

[DOI] [PMC free article] [PubMed] [Google Scholar] 199

As they have an unpaired electron, they are unstable and highly reactive, and seek to steal an electron from other molecules in the body such as from skin cells or blood cells resulting in cell damage and inflammation

The enzyme that produces NAPQI, CYP2E1, is an inducible enzyme and thus, with other substances such as ethanol, can be induced and possibly create more NAPQI and liver injury on its own

Most safety information through 2024 comes from passive reporting systems, single-case reports and small series

Yes, and it's one of the more well-supported pairings in antioxidant supplementation

Xian, Ming